By Sindhu Sundar ( April 5, 2016, 4:20 PM EDT) -- The FDA's enforcement letters this week included its first warning letter by the agency's office of prescription drug promotion, which targeted a head lice product sold by Japanese drugmaker Shionogi & Co. Ltd. for not warning consumers about any risks of the product. The agency's letters this week also highlighted a renewed scrutiny of dietary supplement makers with controversial chemical ingredients including DMAA, while a cheese maker in Michigan was hit with an injunction after the FDA discovered listeria in its facility....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.